Pharmacogenetics determinants of anticancer activity of intravescical gemcitabine in patients with superficial transitional cell carcinoma (TCC) of the bladder

被引：0
|
作者：
De Braud, Filippo
Danesi, Romano
Curigliano, Giuseppe
Giovanetti, Elisa
De Cobelli, Ottavio
De Pas, Tommaso
Mey, Valentina
Spitaleri, Gianluca
Pece, Salvatore
Noberasco, Cristina
Nannizzi, Sara
Verweij, Fabrizio
Renne, Giuseppe
McVie, Gordon
Del Tacca, Mario
机构：
[1] European Inst Oncol, Clin Pharmacol & New Drugs Unit, Milan, Italy
[2] Univ Pisa, Sch Med, Div Pharmacol & Chemotherapy, Pisa, Italy
[3] European Inst Oncol, Div Urol, Milan, Italy
[4] European Inst Oncol, Dept Expt Oncol, Milan, Italy
[5] European Inst Oncol, Dept Pathol, Milan, Italy
[6] European Inst Oncol, Milan, Italy
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3116
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Plasmacytoid transitional cell carcinoma (P-TCC) of urinary bladder: A clinicopathologic study in 7 patients
    Lee, HI
    Jung, SJ
    Lee, S
    Ro, JY
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 151A - 151A
  • [32] Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract
    Novara, Giacomo
    De Marco, Vincenzo
    Dalpiaz, Orietta
    Gottardo, Fedra
    Bouygues, Vianney
    Galfano, Antonio
    Martignoni, Guido
    Patard, Jean Jacques
    Artibani, Walter
    Ficarra, Vincenzo
    [J]. BJU INTERNATIONAL, 2008, 101 (11) : 1368 - 1374
  • [33] Gemcitabine (G) and vinorelbine (V) in pretreated or elderly transitional cell carcinoma (TCC) patients (PTS): A phase II study
    Ferrau, F
    Bordonaro, R
    Aiello, R
    Cordio, S
    Failla, M
    Giuffrida, D
    Lavenia, G
    Pappalardo, A
    Priolo, D
    Failla, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S352 - S352
  • [34] Phase I trial of paclitaxel, cisplatin, and gemcitabine (TCG) in patients (p) with advanced transitional cell carcinoma (TCC) of the urothelium
    Bellmunt, J
    Baselga, J
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 140 - 140
  • [35] Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical cystectomy (RC) in patients with muscle-invasive transitional cell carcinoma (TCC) of the bladder
    Chaudhary, U. B.
    Golshayan, A. R.
    Brisendine, A.
    Kraft, A. S.
    Clarke, H.
    Keane, T. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [36] Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
    Mohanty, N. K.
    Nayak, Rajiba L.
    Vasudeva, Pawan
    Arora, R. P.
    [J]. INDIAN JOURNAL OF UROLOGY, 2008, 24 (01) : 44 - 47
  • [37] Diagnostic value of urinary bladder cancer (UBC) antigen for urinary bladder transitional cell carcinoma (TCC)
    Marshutina, N.
    Sergeeva, N.
    Rodina, I
    Rusakov, I
    Sergeeva, V
    [J]. TUMOR BIOLOGY, 2006, 27 : 52 - 52
  • [38] A phase I trial of intra-vesical gemcitabine in the treatment of recurrent superficial transitional cell carcinoma of the bladder.
    Maddineni, SB
    Sangar, V
    Betts, CD
    O'Flynn, KJ
    Clarke, NW
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S63 - S63
  • [39] ULTRASTRUCTURAL DETERMINATION OF ELEMENTS IN TRANSITIONAL CELL-CARCINOMA (TCC) OF THE URINARY-BLADDER
    FRIEDRICHS, R
    BURCHARD, WG
    RUBBEN, H
    [J]. JOURNAL OF UROLOGY, 1986, 135 (04): : A289 - A289
  • [40] Predictors of outcome in bladder transitional cell carcinoma (TCC) treated by intravesical chemotherapy.
    White, RD
    Deitch, AD
    Daneshmand, S
    Blumenstein, BB
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 145 - 145
12345